Planning Therapy for High-Risk HER2-Positive Early-Stage Breast Cancer: Expert Viewpoint

Optimize your treatment of patients with high-risk HER2+ EBC with this commentary from our expert and then download the slides for use in your own practice.

Share

Program Content

Activities

Therapy for High-Risk HER2+ EBC
Planning Therapy for High-Risk HER2-Positive Early-Stage Breast Cancer: Expert Viewpoint
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: May 12, 2021

Expires: May 11, 2022

Slideset: Therapy for High-Risk HER2+ EBC
Planning Therapy for High-Risk HER2-Positive Early-Stage Breast Cancer: Expert Viewpoint
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: May 12, 2021

Expires: May 11, 2022

Faculty

cover img faculity

Lee Schwartzberg, MD

Professor of Medicine
Chief
Division of Hematology and Oncology
University of Tennessee Health Science Center
Memphis, Tennessee
Executive Director
West Cancer Center
Germantown, Tennessee

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Puma Biotechnology, Inc.